| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | SKLB610 |
|---|
| Description | SKLB610 is a VEGFR inhibitor that potently suppresses human tumor angiogenesis. SKLB610 inhibits angiogenesis-related tyrosine kinase VEGFR2, fibroblast growth factor receptor 2 (FGFR2) and platelet-derived growth factor receptor (PDGFR) at rate of 97%, 65% and 55%, respectively, at concentration of 10 μM in biochemical kinase assays.SKLB610 exhibits its antitumor activity as a multi-targeted inhibitor with more potent inhibition of VEGFR2 activity. MW: 415.36. Purity >98% by HPLC |
|---|
| Size | 5 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | N-Methyl-4-(4-(3-(trifluoromethyl)benzamido)phenoxy)picolinamide |
|---|
| Gene, Accession, CAS # | CAS: 1125780-41-7 |
|---|
| Catalog # | 2610-5 |
|---|
| Price | |
|---|
| Order / More Info | SKLB610 from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|